WhiteLab Genomics

About:

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

Website: https://www.whitelabgx.com

Twitter/X: WhitelabG

Top Investors: Y Combinator, Debiopharm Group, Omnes Capital

Description:

WhiteLab Genomics develops a proprietary platform that leverages graph knowledge technology and machine learning to help companies discover and design new genomic therapies. WhiteLab Genomics enables genomic medicine scientists to obtain precise and comprehensive answers to key scientific and technological questions such as optimizing payload and vector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies. Whitelab Genomics guides its clients through the in-silico development phases, allowing them to quickly develop target vectors and payloads while saving valuable time needed to provide patients with access to new genomic therapies.